- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Mesothelin (MSLN) is a glycosylphosphatidylinositol-anchored cell surface protein with highly restricted expression in normal mesothelial cells lining the pleura, peritoneum, and pericardium, but marked overexpression in malignant mesothelioma and select epithelial cancers. Mesothelin Antibody is widely recognized as a mesothelioma marker antibody due to this distinct expression pattern, enabling reliable identification of mesothelial lineage and tumor-associated mesothelin expression. The strong contrast between limited normal tissue distribution and tumor upregulation makes mesothelin a critical biomarker in cancer research and diagnostic pathology.
Mesothelin antibody, also referred to as MSLN antibody or mesothelioma-associated antigen antibody, produces characteristic membranous and cytoplasmic staining consistent with its cell surface localization and proteolytic processing. In tissue-based assays, expression is largely confined to mesothelial cells under physiologic conditions, while most non-mesothelial tissues demonstrate minimal to absent signal. This restricted baseline expression enhances interpretability and supports high-confidence detection of mesothelin-positive cell populations.
As a mesothelioma marker antibody, this clone provides robust detection of malignant mesothelioma, where strong and diffuse membranous staining is typically observed across tumor cells. Mesothelin expression is also present in a subset of aggressive epithelial malignancies, including ovarian serous carcinoma and pancreatic ductal adenocarcinoma, reflecting its role as a tumor-associated antigen. Importantly, the absence of staining in many other tumor types provides clear diagnostic contrast, aiding in the differentiation of mesothelioma from morphologically overlapping malignancies such as metastatic adenocarcinoma.
This antibody is further distinguished by protein microarray specificity validation using a HuProt(TM) platform comprising over 19,000 full-length human proteins. Clone MSLN/3384 demonstrates a dominant and highly selective binding profile to mesothelin, with a markedly elevated Z-score and strong separation from all secondary signals. This large specificity gap indicates minimal cross-reactivity and provides robust evidence of target selectivity, supporting reliable performance across experimental applications.
Functionally, mesothelin contributes to tumor progression through cell adhesion and interaction with MUC16 (CA125), facilitating tumor cell attachment and dissemination within serosal cavities. Its involvement in cancer biology, combined with its restricted normal tissue expression, underlies its importance as both a diagnostic marker and therapeutic target. Overall, Mesothelin Antibody provides highly specific, high-confidence detection of mesothelin expression, supporting accurate identification of mesothelioma and detailed analysis of mesothelin-associated tumor biology.
This Mesothelin antibody is part of a broader Mesothelin antibody panel offered by NSJ Bioreagents.
Optimal dilution of the Mesothelin Antibody / Mesothelioma Marker Antibody should be determined by the researcher.
A portion of amino acids 273-407 from the human protein was used as the immunogen for the Mesothelin antibody.
Store the Mesothelin antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
MSLN antibody, Mesothelioma marker antibody, Mesothelin antigen antibody, CA125-binding protein antibody, Mesothelial cell marker antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.